Covaxin found to have 77.8 per cent efficacy rate against COVID-19: Lancet
Covaxin, the coronavirus vaccine developed by the government's medical research agency and Bharat Biotech, was found to have a 77.8 per cent efficacy rate against COVID-19. This report was published in a long-awaited analysis published in The Lancet.
